实用医学杂志 ›› 2022, Vol. 38 ›› Issue (11): 1365-1372.doi: 10.3969/j.issn.1006⁃5725.2022.11.012

• 临床研究 • 上一篇    下一篇

脂肪酸酰胺水解酶在不同癌症中的表达及其与预后和免疫微环境的关系

马寒素 陈韵 刘玉琛 曾乐立 许宇智 方烁 陈昱 潘逸航   

  1. 中山大学附属第七医院精准医学中心(广东深圳518107)


  • 出版日期:2022-06-10 发布日期:2022-06-10
  • 通讯作者: 潘逸航 E⁃mail:panyih@mail.sysu.edu.cn
  • 基金资助:
    科技部国家重点研发计划(编号:2018YFA0902801)

Expression of fatty acid amide hydrolase in different types of cancer and its relationship with prognosis and immune microenvironment

MA Hansu,CHEN Yun,LIU Yuchen,ZENG Leli,XU Yuzhi,FANG Shuo CHEN Yu,PAN Yihang.   

  1. Precision Medicine Center,the Seventh Affiliated Hospital,Sun Yat⁃sen University,Shen⁃ zhen 518107,China

  • Online:2022-06-10 Published:2022-06-10
  • Contact: PAN Yihang E⁃mail:panyih@mail.sysu.edu.cn

摘要:

目的 本研究旨在阐明脂肪酸酰胺水解酶(fatty acid amide hydrolase,FAAH)在不同癌症中的表达及其与生存预后、肿瘤免疫微环境的关系。方法 利用 TCGA 数据库 33 种癌症的癌和癌旁组织数 据结合 GTEx 数据库正常组织的转录组和随访生存数据分析癌症中 FAAH 的表达模式和预后的关系,运用 CIBERSORT 算法和 Pearson 相关系数研究 FAAH 表达与肿瘤免疫浸润的相关性。结果 表达图谱显示, FAAH 在乳腺浸润癌、前列腺癌等 7 种癌症中显著高表达(P < 0.001);在肾透明细胞癌、肺鳞癌等 15 种癌 症显著低表达(P < 0.001)。生存分析显示,与低表达 FAAH 患者相比,高表达 FAAH 的肾透明细胞癌、胃 腺癌等多种癌症患者的预后(OS、DSS、DFI、PFI)较好,具有较长的生存时间(P < 0.05)。免疫微环境分析 显示,肾透明细胞癌中 FAAH 低表达组中 CD4+T 记忆细胞与 γδT 细胞显著减少(P < 0.05),胃腺癌中 FAAH 低表达组有较少的单核细胞浸润(P < 0.05)。结论 泛癌分析表明 FAAH 在多种癌症中普遍低表达,且其 低表达与较差的生存预后显著相关,而且 FAAH 的表达与免疫浸润有关,可作为预后生物标志物和癌症 免疫治疗的潜在靶点。

关键词:

脂肪酸酰胺水解酶,  , 预后,  , 免疫浸润,  , 泛癌分析

Abstract:

Objective This study aims to clarify the expression of fatty acid amide hydrolase(FAAH)in different types of cancer and its relationship with survival prognosis and tumor immune microenvironment. Methods The relationship between the expression pattern and prognosis of FAAH in cancer was analyzed by using the cancer and paracancerous tissue data from 33 types of cancer in the TCGA database combined with the transcriptome of normal tissues and follow⁃up survival data in the GTEx database. The CIBERSORT algorithm and Pearson correla⁃ tion coefficient were used to study the correlation between FAAH expression and tumor immune infiltration. Results The expression map showed that FAAH was significantly highly expressed in 7 types of cancer including breast invasive carcinoma and prostate cancer(P < 0.001),whereas lower in 15 types of cancer including renal clear cell carcinoma and lung squamous cell carcinoma(P < 0.001). Survival analysis showed that for clear cell renal cell carcinoma or gastric adenocarcinoma,the patients with higher expression of FAAH had better prognosis than those with lower expression(OS,DSS,DFI,and PFI)and longer survival period(P < 0.05). Immune microenvironment analysis showed that CD4 + T memory cells and γδ T cells were markedly reduced in the lower FAAH expression group with clear cell renal cell carcinoma(P < 0.05),and there was less monocyte infiltration in the lower FAAH expression group with gastric adenocarcinoma(P < 0.05). Conclusions Pan⁃cancer analysis shows that a lower expression of FAAH is common in multiple types of cancer,significantly associating with poor survival prognosis. The expression of FAAH is associated with immune infiltration,which can be used as a prognostic biomarker and a potential target for cancer immunotherapy.

Key words: FAAH, prognosis, immune infiltrate, pan?cancer analysis